IDS is named in Gartner’s Hype Cycle for RTHS Technology Report 2018

Fort Lauderdale, FL, August 9, 2018 – IDS has once again been recognized in the category of Real-Time Health Systems (RTHS) in this Hype Cycle report only this time as a Platform vendor.

According to Gartner, the RTHS is a paradigm that spans the entire set of business and clinical capabilities of a healthcare delivery organization (HDO) as it embraces digital technology. The RTHS is emerging as a connected digital platform to transform every component of care delivery, administration and analytics by putting in the hands of people and machines real-time situational awareness at operational, tactical and strategic levels.

“We remain committed to advancing the digital ecosystem with our cloud platform, clinical applications, and real-time analytics. Offering cost-effective means for enabling organizations to continually evolve and innovate in order to accommodate advances in clinical care, care coordination, new care delivery models and changing business requirements is our pledge.” said Yaniv Dagan, IDS CEO. “IDS’ relentless commitment to making this vision a reality has prompted this recognition as a present vendor in this exclusive space.”

To get access to the full report, click here: Hype Cycle for Real-Time Health System Technology 2018

 

 

Gartner, Hype Cycle for Real-Time Health System Technologies, 2018, Gregg Pessin, Barry Runyon, 25 July 2018
Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.
GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally, and is used herein with permission. All rights reserved.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

clear formSubmit